With $30M In Hand, Zosano Hopes Its Osteoporosis Patch Will Compete With Forteo
This article was originally published in The Pink Sheet Daily
Executive Summary
Despite a long list of potential therapeutic uses for its transdermal patch technology, privately held biotech seeks direct competition in osteoporosis anabolic therapy space.